FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133098859> ?p ?o ?g. }

• W3133098859 abstract "Background Polyvascular atherosclerotic disease is associated with an increased risk of future cardiovascular events. Intensive lipid-lowering therapy (ILT) may mitigate this risk. The aims of this study-level meta-analysis were to examine the effects of ILT in patients with polyvascular disease and whether baseline low-density lipoprotein cholesterol (LDL-C) may determine the level of benefit. Methods and Results Electronic databases were searched through January 2020 to identify randomized controlled trials of treatments targeting upregulation of LDL-C receptors (ie, statins, ezetimibe, and PCSK9 [proprotein convertase subtilisin-kexin type 9] inhibitors). The primary end point was major adverse vascular events as defined by the included studies. A total of 94 362 patients (14 821 [18.6%] with polyvascular disease) from 7 studies were included. In patients with monovascular disease, ILT was associated with a 13% reduction in the primary end point (rate ratio [RR] 0.87; 95% CI, 0.81-0.93 [P=0.0002]) (absolute RR, 1.8%) compared with less ILT, while patients with polyvascular disease had 15% relative RR (0.85; 95% CI, 0.80-0.90 [P<0.00001]) (absolute RR, 6.5%) (P=0.66 for interaction). When factoring LDL-C, unlike patients with monovascular disease, the relative benefits of ILT, compared with less ILT, in patients with polyvascular disease were comparable with LDL-C >100 mg/dL (RR, 0.85; 95% CI, 0.80-0.90 [P<0.00001]) and LDL-C <100 mg/dL (RR, 0.88; 95% CI, 0.81-0.96 [P=0.003]) (P=0.23 for interaction). Conclusions Patients with polyvascular disease experienced comparable benefits to those with monovascular disease in response to ILT. The benefits of ILT in patients with polyvascular disease were not dependent on baseline LDL-C, challenging the approach of using LDL-C as a prerequisite to commence ILT for this high-risk subgroup." @default.
• W3133098859 created "2021-03-01" @default.
• W3133098859 creator A5004173401 @default.
• W3133098859 creator A5012706547 @default.
• W3133098859 creator A5033308586 @default.
• W3133098859 creator A5083118204 @default.
• W3133098859 creator A5088810449 @default.
• W3133098859 date "2021-03-02" @default.
• W3133098859 modified "2023-10-17" @default.
• W3133098859 title "Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease" @default.
• W3133098859 cites W1497216596 @default.
• W3133098859 cites W1523152575 @default.
• W3133098859 cites W16027210 @default.
• W3133098859 cites W1973885325 @default.
• W3133098859 cites W2032619862 @default.
• W3133098859 cites W2082559134 @default.
• W3133098859 cites W2083311650 @default.
• W3133098859 cites W2104365808 @default.
• W3133098859 cites W2116083791 @default.
• W3133098859 cites W2127933204 @default.
• W3133098859 cites W2138650132 @default.
• W3133098859 cites W2142164422 @default.
• W3133098859 cites W2155598961 @default.
• W3133098859 cites W2164551379 @default.
• W3133098859 cites W2468996569 @default.
• W3133098859 cites W2519634482 @default.
• W3133098859 cites W2548346802 @default.
• W3133098859 cites W2554832534 @default.
• W3133098859 cites W2584408389 @default.
• W3133098859 cites W2593665296 @default.
• W3133098859 cites W2737239680 @default.
• W3133098859 cites W2762857438 @default.
• W3133098859 cites W2766232664 @default.
• W3133098859 cites W2768588165 @default.
• W3133098859 cites W2790531075 @default.
• W3133098859 cites W2800876320 @default.
• W3133098859 cites W2888563513 @default.
• W3133098859 cites W2889561304 @default.
• W3133098859 cites W2899223760 @default.
• W3133098859 cites W2940327706 @default.
• W3133098859 cites W2963429759 @default.
• W3133098859 cites W2975198649 @default.
• W3133098859 cites W2995212685 @default.
• W3133098859 cites W2995654354 @default.
• W3133098859 cites W3000428233 @default.
• W3133098859 cites W3183857127 @default.
• W3133098859 cites W424467158 @default.
• W3133098859 doi "https://doi.org/10.1161/jaha.120.017948" @default.
• W3133098859 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8174253" @default.
• W3133098859 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33586467" @default.
• W3133098859 hasPublicationYear "2021" @default.
• W3133098859 type Work @default.
• W3133098859 sameAs 3133098859 @default.
• W3133098859 citedByCount "8" @default.
• W3133098859 countsByYear W31330988592021 @default.
• W3133098859 countsByYear W31330988592022 @default.
• W3133098859 countsByYear W31330988592023 @default.
• W3133098859 crossrefType "journal-article" @default.
• W3133098859 hasAuthorship W3133098859A5004173401 @default.
• W3133098859 hasAuthorship W3133098859A5012706547 @default.
• W3133098859 hasAuthorship W3133098859A5033308586 @default.
• W3133098859 hasAuthorship W3133098859A5083118204 @default.
• W3133098859 hasAuthorship W3133098859A5088810449 @default.
• W3133098859 hasBestOaLocation W31330988591 @default.
• W3133098859 hasConcept C126322002 @default.
• W3133098859 hasConcept C168563851 @default.
• W3133098859 hasConcept C197934379 @default.
• W3133098859 hasConcept C203092338 @default.
• W3133098859 hasConcept C2776839432 @default.
• W3133098859 hasConcept C2778657065 @default.
• W3133098859 hasConcept C44249647 @default.
• W3133098859 hasConcept C71924100 @default.
• W3133098859 hasConcept C82789193 @default.
• W3133098859 hasConcept C90924648 @default.
• W3133098859 hasConceptScore W3133098859C126322002 @default.
• W3133098859 hasConceptScore W3133098859C168563851 @default.
• W3133098859 hasConceptScore W3133098859C197934379 @default.
• W3133098859 hasConceptScore W3133098859C203092338 @default.
• W3133098859 hasConceptScore W3133098859C2776839432 @default.
• W3133098859 hasConceptScore W3133098859C2778657065 @default.
• W3133098859 hasConceptScore W3133098859C44249647 @default.
• W3133098859 hasConceptScore W3133098859C71924100 @default.
• W3133098859 hasConceptScore W3133098859C82789193 @default.
• W3133098859 hasConceptScore W3133098859C90924648 @default.
• W3133098859 hasIssue "5" @default.
• W3133098859 hasLocation W31330988591 @default.
• W3133098859 hasLocation W31330988592 @default.
• W3133098859 hasLocation W31330988593 @default.
• W3133098859 hasOpenAccess W3133098859 @default.
• W3133098859 hasPrimaryLocation W31330988591 @default.
• W3133098859 hasRelatedWork W1547604591 @default.
• W3133098859 hasRelatedWork W1559106817 @default.
• W3133098859 hasRelatedWork W1965952643 @default.
• W3133098859 hasRelatedWork W2024334311 @default.
• W3133098859 hasRelatedWork W2093197048 @default.
• W3133098859 hasRelatedWork W2097281569 @default.
• W3133098859 hasRelatedWork W2307397775 @default.
• W3133098859 hasRelatedWork W2892553243 @default.
• W3133098859 hasRelatedWork W3203317155 @default.
• W3133098859 hasRelatedWork W4362588076 @default.

• next